Hemolytic Uremic Syndrome Following Influenza A (H1N1) pdm09 Virus in a 14-Month-Old Girl Hemolytic Uremic Syndrome Following Influenza
Journal of Pediatric Nephrology,
Vol. 9 No. 3 (2021),
4 September 2021
,
Page 1-5
https://doi.org/10.22037/jpn.v9i3.33834
Abstract
Hemolytic Uremic Syndrome (HUS) is characterized by the clinical triad of microangiopathic non-immune hemolytic anemia, thrombocytopenia, and acute renal failure. There are infections, genetic causes, malignancies, autoimmune diseases, drugs, and many unexplained causes in the etiology of HUS. The most common cause of HUS in children is Shiga toxin-producing Escherichia coli (STEC). In the literature, few influenza A (H1N1) pdm09 virus-related HUS cases are reported. In this case report, a case with hemolytic uremic syndrome associated with influenza A (H1N1) pdm09 virus infection is presented.
- Influenza A (H1N1) pdm09
- Hemolytic Uremic Syndrome
- Nephrotic Syndrome
How to Cite
References
Sens YA, Miorin LA, Silva HG et al. Acute renal failure due to hemolytic uremic syndrome in adult patients. Ren Fail 1997; 19:279–282.
Ardissino G, Salardi S, Colombo E, et al. Epidemiology of haemolytic uremic syndrome in children. Data from the North Italian HUS network. Eur J Pediatr 2016; 175:465.
Siegler R. The hemolytic uremic syndrome. Pediatr Clin North Am 1995; 42: 1505–1529.
Ayala E, Kagawa FT, Wehner JH, et al. Rhabdomyolysis associated with 2009 influenza A(H1N1). JAMA 2009; 302(17):1863-4.
Centers for Disease Control and Prevention (CDC). H1N1 flu. Updated interim recommendations for the use of antiviral medications in the treatment and prevention of influenza for the 2009-2010 season. Available at:http://www.cdc.gov/h1n1flu/recommendations. htm/ Accessed September 24, 2009.
Rothberg MB, Haessler SD. Complications of seasonal and pandemic influenza. Crit Care Med 2009. [Epub ahead of print].
Centers for Disease Control and Prevention (CDC). Neurologic complications associated with novel influenza A (H1N1) virus infection in children - Dallas, Texas, May 2009. Morb Mortal Wkly Rep 2009;58(28):773-8.
Bento D, Mapril J, Rocha C, Marchbank KJ et al., Triggering of atypical hemolytic uremic syndrome by influenza A (H1N1). Renal Failure 2010; 32:6, 753-756.
Farinha A, Carrilho P, Felgueiras J, Natário A, Assunção J, Vinhas J. Haemolytic uraemic syndrome associated with H1N1 influenza. NDT Plus. 2010;3(5):447-448.
Çaltik A, Akyüz SG, Erdogan O, Demircin G. Hemolytic uremic syndrome triggered with a new pandemic virus: influenza A (H1N1). Pediatr Nephrol (2011) 26:147–148.
Watanabe T (2001) Hemolytic uremic syndrome associated with influenza A virus infection. Nephron 89:359–360.
Koh YR, Hwang SH, Chang CL, Lee EY, Son HC, Kim HH. Thrombotic thrombocytopenic purpura triggered by influenza A virus subtype H1N1 infection. Transfus Apher Sci. 2012;46(1):25-28.
Golubovic E, Miljkovic P, Zivic S, Jovancic D, Kostic G (2011) Hemolytic uremic syndrome associated with novel influenza A H1N1 infection. Pediatr Nephrol 26:149–150.
Tsujii N, Nogami K, Yoshizawa H, Hayakawa M, Isonishi A, Matsumoto M, Shima M (2016) Influenza-associated thrombotic microangiopathy with unbalanced von Willebrand factor and a disintegrin and metalloproteinase with a thrombospondin type 1 motif, member 13 levels in a heterozygous protein S-deficient boy. Pediatr Int 58:926–929.
Igarashi T, Ito S, Sako M, Saitoh A, Hataya H, Mizuguchi M, et al. Study group for establishing guidelines for the diagnosis and therapy of hemolytic uremic syndrome. Guidelines for the management and investigation of hemolytic uremic syndrome. Clin Exp Nephrol. 2014 Aug;18(4):525-57.
Flynn JT, Kaelber DC, Baker-Smith CM, et al. Clinical Practice Guideline for Screening and Management of High Blood Pressure in Children and Adolescents. Pediatrics 2017; 140.
Printza N, Roilides E, Kotsiou M, et al. Pandemic influenza A (H1N1) 2009-associated hemolytic uremic syndrome. Pediatr Nephrol. 2011; 26:143–144.
Bento D, Mapril J, Rocha C, et al. Triggering of atypical hemolytic uremic syndrome by influenza A (H1N1). Ren Fail. 2010; 32:753–756.
Trachtman H, Sethna C, Epstein R, et al. Atypical hemolytic uremic syndrome associated with H1N1 influenza A virüs infection. Pediatr Nephrol. 2011; 26:145–146.
Huang RT, Dietsch E, Rott R. Further studies on the role of neuraminidase and the mechanism of low pH dependence in influenza virus-induced membrane fusion. J Gen Virol. 1985;66 (pt 2):295–301.
Cochran JB, Panzarino VM, Maes LY, et al. Pneumococcusinduced T antigen activation in hemolytic uremic syndrome and anemia. Pediatr Nephrol. 2004;1 9:317–321.
Gruppo RA, Rother RP. Eculizumab for congenital atypical hemolytic-uremic syndrome. N Engl J Med. 2009; 360: 544-6.
Licht C, Greenbaum LA, Muus P, et al. Efficacy and safety of eculizumab in atypical hemolytic uremic syndrome from 2-year extensions of phase 2 studies. Kidney Int. 2015; 87: 1061-73.
Rhee H, Song SH, Lee YJ, Choi HJ, Ahn JH, Seong EY, Lee SB, Kwak IS. Pandemic H1N1 influenza A viral infection complicated by atypical hemolytic uremic syndrome and diffuse alveolar hemorrhage. Clin Exp Nephrol. 2011 Dec;15(6):948-52.
- Abstract Viewed: 147 times
- PDF Downloaded: 149 times